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CASE REPORT
Neurosyphilis as a great imitator: a case 
report
Liis Sabre1,2*, Mark Braschinsky1,2 and Pille Taba1,2
Abstract 
Background: Neurosyphilis is defined as any involvement of the central nervous system by the bacterium 
Treponema pallidum. Movement disorders as manifestations of syphilis have been reported quite rarely.
Case presentation: We report a case of a 42-year-old Russian man living in Estonia with rapidly progressive demen-
tia and movement disorders manifesting as myoclonus, cerebellar ataxia and parkinsonism. The mini mental state 
examination score was 12/30. After excluding different neurodegenerative causes, further diagnostic testing was 
consistent with neurosyphilis. Treatment with penicillin was started and 6 months later his mini mental state examina-
tion score was 25/30 and he had no myoclonus, parkinsonism or cerebellar dysfunction.
Conclusion: Since syphilis is easily diagnosed and treatable, it should be considered and tested in patients with 
cognitive impairment and movement disorders.
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Background
Neurosyphilis is defined as any involvement of the cen-
tral nervous system by the bacterium Treponema palli-
dum. The annual incidence of neurosyphilis varies from 
0.16 to 2.1 per 100,000 population [1]. It may involve the 
central nervous system at any stage of syphilitic infection. 
Early neurosyphilis manifests as meningitis, meningo-
vascular syphilis or asymptomatic neurosyphilis [2]. Late 
neurosyphilis usually affects the brain and spinal cord, 
presenting as paretic neurosyphilis (general paresis) with 
neuropsychiatric manifestations including dementia, or 
tabetic neurosyphilis (tabes dorsalis) characterised by 
sensory ataxia, peripheral neuropathy and cranial nerve 
lesions. Movement disorders as manifestations of syphilis 
have been reported quite rarely [3, 4].
Here we describe a case of neurosyphilis presenting 
with parkinsonism, myoclonus, cerebellar ataxia and 
rapidly progressive dementia whose neurologic condi-
tion greatly improved after the antibiotic treatment with 
penicillin-G.
Case presentation
A 42-year-old previously healthy Russian man living in 
Estonia was hospitalised due to a one-year history of pro-
gressive cognitive decline, confusion attacks, rare hallu-
cinations, gait disturbances and involuntary movements.
At the beginning of the symptoms he was often sent on 
short sick leaves because of his employer’s doubt about 
his health. He resigned 6 months after the first symptoms 
appeared, being unable to perform his duties at work.
In addition, his spouse could not allow him to leave 
home due to his progressive disorientation. The patient 
became unable to cope with daily activities like dressing, 
brushing teeth and washing. He soon became depend-
ent in most daily life activities. Therewith, he came to the 
neurologist for the first time.
On neurological examination he had predominantly 
left-sided bradykinesia and rigidity and intentional 
tremor in his left hand and both legs. There was no weak-
ness on motor examination. Deep tendon reflexes were 
brisk and more pronounced in the left but there were no 
extensor reflexes. His gate was cautious and wide-based. 
There were myoclonic jerks in his legs and left arm that 
were more pronounced in action (stimulus-sensitive) 
(Additional file  1). According to the neuropsychological 
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testing he had severe dementia with the mini men-
tal state examination (MMSE) Score 12/30. The results 
were affected by severe attention deficit. He had affec-
tive symptoms like irritability, aggressive behaviour and 
delusions. His speech was dysarthric and dysphonic with 
mixed aphasia that included difficulties in word finding, 
impaired articulatory agility, verbal stereotypes, some 
paraphasias in running speech and difficulties in under-
standing longer sentences. He had anisocoria (the left 
pupil was larger), with pupils nonreactive to light, and 
horizontal nystagmus.
Head magnetic resonance imaging (MRI) scan revealed 
brain atrophy (Fig.  1). There was focal slowing and epi-
leptiform discharges in the right fronto-temporal regions 
on the electroencephalography (EEG) (Fig. 2).
Blood tests were normal including hepatic function 
and thyroid tests, although the level of vitamin B12 was 
slightly decreased (124  pmol/l, reference range 141–
489  pmol/l). Human immunodeficiency virus (HIV) 1 
and 2 antibodies were negative but the rapid plasma 
reagin (RPR) test as well as the T. pallidum hemaggluti-
nation assay (TPHA) were highly positive (RPR 1:32 and 
TPHA 1:1520) in serum as well as in cerebrospinal fluid 
(CSF) (RPR 1:8 and TPHA 1:640). CSF showed predomi-
nantly lymphocytic pleocytosis (12 cells/mm3), the pro-
tein was elevated to 0.63 g/l, as well as IgG index (4.31).
Based on clinical pictures and laboratory data, neuro-
syphilis was diagnosed and intravenous penicillin-G treat-
ment 24 million units per day for 14  days was initiated. 
Thereafter intramuscular benzathine penicillin of 2.4 mil-
lion units once per week was injected for 3 weeks. Com-
plementary treatment with divalproex sodium was started 
as there were epileptiform discharges on the EEG that 
demonstrated an increased risk for developing of epilepsy, 
and the patient had emotional problems and agitation.
On the follow-up 6 months later, he had a mild demen-
tia (MMSE 25/30), but there were neither myoclonus nor 
parkinsonism. Deep tendon reflexes were still brisk but 
symmetrical. He still had Adie’s tonic pupil in the left and 
very little constriction to direct light bilaterally. No clini-
cal features of cerebellar dysfunction were detected. Both 
the serological markers [RPR (1:2) and TPHA] and the 
above mentioned CSF measures changed to negative.
The patient continued treatment with divalproex 
sodium 300  mg bid, and enalapril with amlodipine for 
hypertension. On the subsequent follow-up visits (twice 
a year), no consistent changes have been found.
Discussion
Neurosyphilis is a “great imitator”. Its clinical manifes-
tations lack specificity and may mimic several other 
disorders [3]. In clinical manifestations of meningeal 
Fig. 1 Brain axial fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging of the patient (42-year-old male) showing asymmetrical 
brain atrophy, more pronounced in the right hemisphere
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neurosyphilis acute viral meningitis, basal meningitis 
caused by tuberculosis or meningitis by other microor-
ganism should be considered. Meningovascular syphilis 
manifests as a stroke and in our case the movement dis-
order could have been induced by lesion in the midbrain, 
basal ganglia or cerebellum [3].
The most frequent clinical feature of general paresis is 
cognitive impairment. Parkinsonism and hyperkinetic 
manifestations are not often reported in neurosyphilis 
and the differential diagnosis may be challenging [4, 5]. 
Psychiatric symptoms are frequent in neurosyphilis and 
are commonly managed with neuroleptic agents. On 
the other hand, drug induced movement disorders may 
develop quite rapidly after initiation of drugs that block 
dopamine receptors so that the sequentiality might not 
be detected. In our case report, the patient had not taken 
any neuroleptics nor other medication that could cause 
parkinsonism before he was admitted to the hospital. 
Slightly reduced levels of vitamin B12 is seen frequently 
in everyday neurologic practice and can hardly explain 
or contribute to the clinical picture seen in this patient. 
In addition, movement disorders can be coincidental 
with infections [4]. Therefore, assessing core criteria of 
Parkinson’s disease, searching for red flags for atypical 
parkinsonism and going through all the possible differen-
tial diagnosis is important. Furthermore, the prospective 
follow up of our patient showed improvement in clini-
cal picture after the antibiotic treatment, confirming the 
causative role of neurosyphilis.
We live in the antibiotic era, but the incidence of 
syphilis is increasing although no resistance to penicil-
lin has been detected. Neurosyphilis requires 3–4 mil-
lion units of intravenous aqueous crystalline penicillin 
G every 4 h for 10–14 days [6, 7]. As some authorities 
recommend benzathine penicillin 7.2 million units total 
as three doses intramuscularly after treatment of neu-
rosyphilis, we also continued the treatment with benza-
thine penicillin 2.4 million units intramuscularly once 
per week for 3 weeks [2, 6]. The recommended follow-
up is every 6  months with CSF examination. Retreat-
ment should be considered if cell count in CSF is not 
decreased after 6  months or cell count and protein in 
CSF has not normalised after 2  years [6, 7]. In recent 
years, men having sex with men has accounted for an 
increasing proportion of syphilis, and co-infection with 
HIV has changed its clinical and laboratory profiles, 
demonstrating a more malignant course and higher 
antigen titres [2, 8].
Fig. 2 Electroencephalography demonstrating focal slowing and epileptiform discharges in the right fronto-temporal regions of a 42-year old male
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The prognosis in early neurosyphilis is quite good and 
the clinical manifestations of patients with meningeal 
neurosyphilis or with gummas will usually resolve [6]. In 
patients with parenchymatous form of neurosyphilis the 
recovery will not be complete, as in our case.
Neurosyphilis is a treatable cause of dementia and 
movement disorders, and the disorder must be consid-
ered as a possible diagnosis in the routine workup of 
patients with cognitive decline and movement disorders. 
In order to achieve the best outcome and avoid a reduc-
tion in the patients’ quality of life, an early diagnosis and 
treatment of neurosyphilis should be applied to prevent 
an irreversible state of the disease with a poor response 
to antibiotics [7, 9, 10].
Conclusions
We present a case of neurosyphilis that manifested with 
cognitive decline, neuropsychiatric features like irrita-
bility and hallucinations, speech disturbances, pupillary 
defect (tonic pupil in the left, a certain degree of mydri-
asis with diminished reaction to light), parkinsonism, 
myoclonus and cerebellar ataxia. This was most likely 
the cerebral parenchymal form of infection, a clinical 
type of late-stage syphilis. The patient was treated with 
penicillin and his symptoms either disappeared (parkin-
sonism, myoclonus and cerebellar dysfunction) or greatly 
improved (dementia).
Since syphilis is easily diagnosed and treatable, it 
should be considered and tested in patients with cogni-
tive impairment and movement disorders. Missing the 
diagnosis of syphilis is a serious medical mistake that 
may affect a long-term outcome.
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